about
Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17Unique transcriptomic signature of omental adipose tissue in Ossabaw swine: a model of childhood obesityHigh-throughput identification and characterization of novel, species-selective GPR35 agonists.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retinaThe antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues.Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineMultiple tyrosine metabolites are GPR35 agonists.Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis.GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?Aspirin metabolites are GPR35 agonists.Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
P2860
Q28116529-49ADDC5E-411A-4302-ACCE-511B2C75693EQ33701881-7EADA66E-3A20-4ED3-A08A-F4272D3AB62FQ34520909-F7E00837-56E2-437F-AF63-B873282801D7Q35425244-F3FAB9A9-A992-4E25-A398-A9819906807CQ37122933-C0778FD7-6B35-4B1D-BCB9-BEF7B362D0C2Q37388865-816C9475-643E-4282-8578-93AC607078B8Q37405405-5D034F47-9008-46B8-A07E-3B117D9BAAFEQ38014830-F01EA451-A908-4F60-9FD8-94F23A1BBED9Q38389922-43D031AD-41DB-46C9-B6A1-795D3FB33D7FQ39176941-B64D1AD5-DF87-4A77-9C10-A600ACF0A273Q39594022-B64BBC1C-1A15-4AD8-9E32-FA102B4CF228Q39731165-C5B857FF-3ABF-400A-9A27-EAA47F3AB4E3Q39867411-691B3562-CD73-4F8B-96A0-949713DA1833Q41401817-D6EC7B6B-B4DD-4BE1-A1A2-67CFB458C992Q41572995-08272A91-E4CF-4FF1-9F60-002D6CE1B5ACQ42538150-41ED7D62-CC30-402F-BE48-7D1FB5019D81Q47413203-B739CCAD-157D-48C8-986A-DEB5AA106C93Q47606629-7F7DE594-F639-4315-A3F1-806CEEC3406CQ53172752-9F15696D-61F8-4AC6-909F-50B4AB40AB0FQ57052680-06B76D56-1777-402D-858C-075F6B71DE8B
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
GPR35 as a Novel Therapeutic Target.
@en
GPR35 as a Novel Therapeutic Target.
@nl
type
label
GPR35 as a Novel Therapeutic Target.
@en
GPR35 as a Novel Therapeutic Target.
@nl
prefLabel
GPR35 as a Novel Therapeutic Target.
@en
GPR35 as a Novel Therapeutic Target.
@nl
P2093
P2860
P356
P1476
GPR35 as a Novel Therapeutic Target
@en
P2093
A E Mackenzie
D L Taylor
G Milligan
J E Lappin
P2860
P356
10.3389/FENDO.2011.00068
P577
2011-11-09T00:00:00Z